Related Experiment Video
Updated: Aug 15, 2026
04:32
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
Quantitative detection of platelet GPIIb-IIIa receptor antagonist activity using a flow cytometric method
Journal of Clinical Laboratory Analysis
|July 22, 1998
Summary
A new assay measures glycoprotein (GP) IIb-IIIa receptor occupancy on platelets. This method is crucial for developing new cardiovascular drugs that target platelet aggregation.
Area of Science:
- Cardiovascular Pharmacology
- Hematology
- Biochemistry
Background:
- Platelet surface receptors, particularly glycoprotein (GP) IIb-IIIa, are key targets for cardiovascular disease pharmacologic interventions.
- GP IIb-IIIa plays a critical role in platelet aggregation and thrombus formation by binding fibrinogen upon activation.
- New drugs targeting GP IIb-IIIa aim to inhibit platelet aggregation, necessitating methods to assess drug efficacy and receptor occupancy.
Purpose of the Study:
- To develop and validate a novel technique for measuring GP IIb-IIIa receptor occupancy on human platelets.
- To establish a reliable assay for assessing the binding of fibrinogen to activated platelets.
- To provide a tool for evaluating the clinical efficacy and safety of new antiplatelet agents.
Main Methods:
- Development of an assay utilizing activated human platelets incubated with biotinylated fibrinogen (Fb-biotin) and antibiotin-FITC.
- Flow cytometric analysis to quantify the extent of Fb-biotin binding to activated platelets.
- Evaluation of the assay's sensitivity to incubation temperature, stability, and inhibition by the GP IIb-IIIa antagonist echistatin.
Main Results:
- Fb-biotin demonstrated rapid binding to activated platelets, with detection influenced by incubation temperature.
- Pre-incubation with echistatin inhibited Fb-biotin binding in a concentration-dependent manner, validating the assay's specificity.
- The fluorescence signal remained stable for two weeks when samples were stored under cold conditions.
Conclusions:
- The developed assay is a simple, cost-effective method for measuring GP IIb-IIIa receptor occupancy.
- This technique can be readily adapted for clinical evaluations of novel antiplatelet drugs targeting the GP IIb-IIIa receptor.
- Accurate measurement of receptor occupancy is vital for the safe and effective use of new cardiovascular pharmacologic agents.
